In breast cancer, PTEN inactivation, mainly through gene deletions, occurs in 5% of hormone receptor (HR) +/HER2- metastatic breast cancer (MBC) and leads to tumorigenesis and tumor progression [2]. Here, NR4A1 is linked to breast cancer.